Your browser doesn't support javascript.
loading
Population pharmacokinetics of sildenafil in extremely premature infants.
Gonzalez, Daniel; Laughon, Matthew M; Smith, P Brian; Ge, Shufan; Ambalavanan, Namasivayam; Atz, Andrew; Sokol, Gregory M; Hornik, Chi D; Stewart, Dan; Mundakel, Gratias; Poindexter, Brenda B; Gaedigk, Roger; Mills, Mary; Cohen-Wolkowiez, Michael; Martz, Karen; Hornik, Christoph P.
Afiliação
  • Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Laughon MM; Department of Pediatrics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Smith PB; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
  • Ge S; Duke Clinical Research Institute, Durham, NC, USA.
  • Ambalavanan N; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Atz A; Division of Neonatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Sokol GM; Department of Pediatrics, Medical University of South Carolina Children's Hospital, Charleston, SC, USA.
  • Hornik CD; Section of Neonatal-Perinatal Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Stewart D; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
  • Mundakel G; Duke Clinical Research Institute, Durham, NC, USA.
  • Poindexter BB; Department of Pharmacy, Duke University Medical Center, Durham, NC, USA.
  • Gaedigk R; University of Louisville Norton Children's Hospital, Louisville, KY, USA.
  • Mills M; Kings County Hospital Center/SUNY Downstate Medical Center, Brooklyn, NY, USA.
  • Cohen-Wolkowiez M; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Martz K; Department of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy-Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
  • Hornik CP; Duke Clinical Research Institute, Durham, NC, USA.
Br J Clin Pharmacol ; 85(12): 2824-2837, 2019 12.
Article em En | MEDLINE | ID: mdl-31475367
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recém-Nascido Prematuro / Inibidores da Fosfodiesterase 5 / Citrato de Sildenafila / Modelos Biológicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant / Newborn Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recém-Nascido Prematuro / Inibidores da Fosfodiesterase 5 / Citrato de Sildenafila / Modelos Biológicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant / Newborn Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2019 Tipo de documento: Article